RNU1-153P

Across TCGA pan-cancer cohorts, RNU1-153P RNA differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of RNU1-153P’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where RNU1-153P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RNU1-153P is over-expressed in tumor, although a few such as UCEC and LUAD show the opposite, repressed pattern.

HNSC, CHOL, and UCEC are the cancer types where RNU1-153P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RNU1-153P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	All	All	+0.278	.011	4	view →
CHOL	All	All	+1.463	<.001	3	view →
UCEC	All	All	−0.643	.049	2	view →
LUAD	Male	III,IV	−1.003	.028	1	view →
KIRC	Female	IV	−0.901	.002	1	view →
LUSC	All	II,III,IV	−0.584	.022	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

RNU1-153P–HNSC

Open the HNSC breakdown →